SCHEMBL7175387

SCHEMBL7175387

O=C1CC(SCc2ccccn2)N1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.42
TSHR P16473 2/20 0.42
ALDH1A1 P00352 1/20 0.42
DDB1 Q16531 1/20 0.41
CRBN Q96SW2 1/20 0.41
KDM4E B2RXH2 1/20 0.41
DAO P14920 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
LMNA P02545 3/20 0.40
HSD17B10 Q99714 1/20 0.39
GLA P06280 1/20 0.39
CYP2E1 P05181 1/20 0.38
CYP2C8 P10632 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2B6 P20813 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8658683 0.72 TSHR (0.42) CYP1A2TSHRALDH1A1KDM4ELMNA
Hydrochloric Acid SCHEMBL7174333 0.72 ALDH1A1 (0.42) CYP1A2TSHRALDH1A1KDM4EDAO
Hydrochloric Acid SCHEMBL7174330 0.72 ALDH1A1 (0.42) CYP1A2TSHRALDH1A1KDM4EDAO
SCHEMBL7180273 0.69 CTRB1 (0.43) CYP1A2TSHRALDH1A1KDM4ESMN1; SMN2
SCHEMBL7180279 0.69 CTRB1 (0.43) CYP1A2TSHRALDH1A1KDM4ESMN1; SMN2
SCHEMBL6130015 0.67 CYP1A2 (0.63) CYP1A2TSHRALDH1A1KDM4EDAO
SCHEMBL11445226 0.67 SMN1; SMN2 (0.57) CYP1A2TSHRALDH1A1KDM4ENPC1
SCHEMBL8553198 0.67 ALKBH5 (0.43) TSHRALDH1A1KDM4ENPC1RAB9A
SCHEMBL7342712 0.67 DDB1 (0.42) ALDH1A1DDB1CRBNKDM4ENPC1
SCHEMBL8441232 0.66 DAO (0.40) CYP1A2ALDH1A1DAORAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1021404-B1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF HCMV INFECTIONS BOEHRINGER INGELHEIM CA LTD (CA) 2003-01-08 EP disclosed
US-6239125-B1 ANTIVIRAL AGENTS AGAINST HERPES VIRUSES. BOEHRINGER INGELHEIM (CANADA) LTD. (CA) 2001-05-29 US disclosed
EP-1021404-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF HCMV INFECTIONS BOEHRINGER INGELHEIM (CANADA) LTD. (CA) 2000-07-26 EP disclosed
WO-1999018071-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF HCMV INFECTIONS BOEHRINGER INGELHEIM (CANADA) LTD. (CA) 1999-04-15 WO disclosed